| Financial Year |
March 31 2023 |
| Monetary Funds |
1,115,763,281.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
517,283,026.32 |
| Accounts Receivable |
1,313,102,645.03 |
| Advances to Suppliers |
851,680,069.39 |
| Other Receivables |
1,806,952.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,395,930,350.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,301,306.11 |
| Total Current Assets |
5,980,567,910.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
13,624,171.18 |
| Fixed Assetes |
365,372,985.48 |
| Under-construction Projects |
356,396,836.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
140,135,158.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
28,983,499.87 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
919,865,305.09 |
| Total Assets |
6,900,433,215.56 |
| Short-Term Loans |
228,439,614.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,007,039,676.88 |
| Accounts Payable |
138,855,584.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,731,526.79 |
| Taxes Payable |
40,545,111.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,922,047.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
165,440.15 |
| Other Current Liabilities |
34,757,340.24 |
| Sub-Total of Current Liabilities |
2,729,820,498.39 |
| Long-term Loans |
9,908,870.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,852,165.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,003,586.37 |
| Total Liabilities |
2,767,824,084.76 |
| Paid-In Capital(Or Share Stock) |
492,829,181.00 |
| Capital Surplus |
1,979,998,635.30 |
| Surplus Reserve |
158,044,286.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,390,773,646.92 |
| Minority Stockholder's Interest |
110,963,380.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,021,645,750.08 |
| Owner's Equity（Stockholder's Equity） |
4,132,609,130.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,900,433,215.56 |
